Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 01, 2007 (Vol. 27, No. 3)

Cell and Molecular Biology News, Books, Tools and Resources

URL:www.cellbiol.com
  • Bursting with info
  • None
Mix up to the minute news stories on biomedical research with miscellaneous science news stories, tech news stories, a great collection of links, and even a relevant set of advertisements (thanks, Google ads), and you’ve got this site. There’s even a set of links to on-line games for scientists who want entertainment “while the gels run.” I get the feeling looking at the site that I’m looking at the appearance of bio-websites of the future. Virtually everything here screams out “click on me,” and, to be honest, that isn’t bad, even if the offering is an advertisement. How can you not click on a link titled Treatments for Dog Cancer? The news stories are great and will be the main continuing draw to the site. A site that I suspect will be bookmarked by many, cellbiol.com is worth a look, even by the skeptical.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »